AAAAAA
Results: 1-25/52
Authors:
Postert, T
Federlein, J
Rose, J
Przuntek, H
Weber, S
Buttner, T
Citation: T. Postert et al., Ultrasonic assessment of physiological echo-contrast agent distribution inbrain parenchyma with transient response second harmonic imaging, J NEUROIMAG, 11(1), 2001, pp. 18-24
Authors:
Naumann, A
Bierbrauer, J
Przuntek, H
Daum, I
Citation: A. Naumann et al., Attentive and preattentive processing in narcolepsy as revealed by event-related potentials (ERPs), NEUROREPORT, 12(13), 2001, pp. 2807-2811
Authors:
Kruger, R
Schols, L
Muller, T
Kuhn, W
Woitalla, D
Przuntek, H
Epplen, JT
Riess, O
Citation: R. Kruger et al., Evaluation of the gamma-synuclein gene in German Parkinson's disease patients, NEUROSCI L, 310(2-3), 2001, pp. 191-193
Authors:
Haussermann, P
Kuhn, W
Przuntek, H
Muller, T
Citation: P. Haussermann et al., Integrity of the blood-cerebrospinal fluid barrier in early Parkinson's disease, NEUROSCI L, 300(3), 2001, pp. 182-184
Authors:
Eising, EG
Muller, T
Freudenberg, L
Muller, SP
Dutschka, K
Sonnenschein, W
Przuntek, H
Bockisch, A
Citation: Eg. Eising et al., SPECT imaging with [I-123]-beta-CIT in Parkinsonism: comparison of SPECT images obtained by a single-headed and a three-headed gamma camera, NUCL MED C, 22(2), 2001, pp. 145-150
Authors:
Kruger, R
Kuhn, W
Leenders, KL
Sprengelmeyer, R
Muller, T
Woitalla, D
Portman, AT
Maguire, RP
Veenma, L
Schroder, U
Schols, L
Epplen, JT
Riess, O
Przuntek, H
Citation: R. Kruger et al., Familial parkinsonism with synuclein pathology - Clinical and PET studies of A30P mutation carriers, NEUROLOGY, 56(10), 2001, pp. 1355-1362
Authors:
Agelink, MW
Andrich, J
Postert, T
Wurzinger, U
Zeit, T
Klotz, P
Przuntek, H
Citation: Mw. Agelink et al., Relation between electro convulsive therapy, cognitive side effects, neuron specific enolase, and protein S-100, J NE NE PSY, 71(3), 2001, pp. 394-396
Authors:
Schulte, T
Mattern, R
Berger, K
Szymanski, S
Klotz, P
Kraus, PH
Przuntek, H
Schols, L
Citation: T. Schulte et al., Double-blind crossover trial of trimethoprim-sulfamethoxazole in spinocerebellar ataxia type 3/Machado-Joseph disease, ARCH NEUROL, 58(9), 2001, pp. 1451-1457
Authors:
Aktas, O
Ari, N
Rieks, M
Hoffmann, V
Schimrigk, S
Przuntek, H
Pohlau, D
Citation: O. Aktas et al., Multiple sclerosis: modulation of apoptosis susceptibility by glatiramer acetate, ACT NEUR SC, 104(5), 2001, pp. 266-270
Authors:
Kruger, R
Menezes-Saecker, AMV
Schols, L
Kuhn, W
Muller, T
Woitalla, D
Berg, D
Berger, K
Przuntek, H
Epplen, JT
Riess, O
Citation: R. Kruger et al., Genetic analysis of the alpha 2-macroglobulin gene in early- and late-onset Parkinson's disease, NEUROREPORT, 11(11), 2000, pp. 2439-2442
Authors:
Wintermeyer, P
Kruger, R
Kuhn, W
Muller, T
Woitalla, D
Berg, D
Becker, G
Leroy, E
Polymeropoulos, M
Berger, K
Przuntek, H
Schols, L
Epplen, JT
Riess, O
Citation: P. Wintermeyer et al., Mutation analysis and association studies of the UCHL1 gene in German Parkinson's disease patients, NEUROREPORT, 11(10), 2000, pp. 2079-2082
Authors:
Schols, L
Szymanski, S
Peters, S
Przuntek, H
Epplen, JT
Hardt, C
Riess, O
Citation: L. Schols et al., Genetic background of apparently idiopathic sporadic cerebellar ataxia, HUM GENET, 107(2), 2000, pp. 132-137
Authors:
Przuntek, H
Muller, T
Citation: H. Przuntek et T. Muller, Non-dopaminergic treatment of Parkinson's disease - Guest editors' introduction, J NEUROL, 247, 2000, pp. 2-2
Authors:
Przuntek, H
Citation: H. Przuntek, Non-dopaminergic therapy in Parkinson's disease, J NEUROL, 247, 2000, pp. 19-24
Authors:
Muller, T
Schafer, S
Kuhn, W
Przuntek, H
Citation: T. Muller et al., Correlation between tapping and inserting of pegs in Parkinson's disease, CAN J NEUR, 27(4), 2000, pp. 311-315
Authors:
Epplen, JT
Gencik, M
Epplen, A
Andrich, J
Saft, C
Przuntek, H
Citation: Jt. Epplen et al., Morbus Huntington - a human genetic model disease, CYTOG C GEN, 91(1-4), 2000, pp. 90-96
Authors:
Kruger, R
Hardt, C
Tschentscher, F
Jackel, S
Kuhn, W
Muller, T
Werner, J
Woitalla, D
Berg, D
Kuhnl, N
Fuchs, GA
Santos, EJM
Przuntek, H
Epplen, JT
Schols, L
Riess, O
Citation: R. Kruger et al., Genetic analysis of immunomodulating factors in sporadic Parkinson's disease, J NEURAL TR, 107(5), 2000, pp. 553-562
Authors:
Rahbar, A
Kempkes, M
Muller, T
Reich, S
Welter, FL
Meves, S
Przuntek, H
Bolt, HM
Kuhn, W
Citation: A. Rahbar et al., Glutathione S-transferase, polymorphism in Parkinson's disease, J NEURAL TR, 107(3), 2000, pp. 331-334
Authors:
Kraus, PH
Przuntek, H
Kegelmann, A
Klotz, P
Citation: Ph. Kraus et al., Motor performance: normative data, age dependence and handedness, J NEURAL TR, 107(1), 2000, pp. 73-85
Authors:
Woitalla, D
Karwasz, R
Muller, T
Przuntek, H
Kuhn, W
Citation: D. Woitalla et al., The activity of Catechol-O-Methyltransferase in parkinsonian patients with"on-off fluctuations", J NEURAL TR, 107(1), 2000, pp. 105-111
Authors:
Muller, T
Woitalla, D
Schulz, D
Peters, S
Kuhn, W
Przuntek, H
Citation: T. Muller et al., Tolcapone increases maximum concentration of levodopa, J NEURAL TR, 107(1), 2000, pp. 113-119
Authors:
Postert, T
Hoppe, P
Federlein, J
Helbeck, S
Ermert, H
Przuntek, H
Buttner, T
Wilkening, W
Citation: T. Postert et al., Contrast agent specific imaging modes for the ultrasonic assessment of parenchymal cerebral echo contrast enhancement, J CEREBR B, 20(12), 2000, pp. 1709-1716
Authors:
Peters, S
Schweibold, G
Przuntek, H
Muller, T
Citation: S. Peters et al., Loss of visual acuity under dopamine substitution therapy, NEURO-OPHTH, 24(1), 2000, pp. 273-277
Authors:
Poehlau, D
Kiltz, U
Rieks, M
Hoffmann, V
Rebmann, V
Schimrigk, S
Grosse-Wilde, H
Przuntek, H
Citation: D. Poehlau et al., Therapeutic immunoadsorption increases the level of circulating soluble HLA molecules, VOX SANGUIN, 78(2), 2000, pp. 119-121
Authors:
Postert, T
Hoppe, P
Federlein, J
Przuntek, H
Buttner, T
Helbeck, S
Ermert, H
Wilkening, W
Citation: T. Postert et al., Ultrasonic assessment of brain perfusion, STROKE, 31(6), 2000, pp. 1460-1461